PE20060740A1 - Proceso de fabricacion de derivados de salicilamidas n-sustituidas - Google Patents

Proceso de fabricacion de derivados de salicilamidas n-sustituidas

Info

Publication number
PE20060740A1
PE20060740A1 PE2005001448A PE2005001448A PE20060740A1 PE 20060740 A1 PE20060740 A1 PE 20060740A1 PE 2005001448 A PE2005001448 A PE 2005001448A PE 2005001448 A PE2005001448 A PE 2005001448A PE 20060740 A1 PE20060740 A1 PE 20060740A1
Authority
PE
Peru
Prior art keywords
substituted
salicilamides
derivatives
manufacturing process
saliciloyl
Prior art date
Application number
PE2005001448A
Other languages
English (en)
Spanish (es)
Inventor
Bernhard Riss
Ulrich Meier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34090175&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20060740(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20060740A1 publication Critical patent/PE20060740A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PE2005001448A 2004-12-16 2005-12-14 Proceso de fabricacion de derivados de salicilamidas n-sustituidas PE20060740A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0427603.6A GB0427603D0 (en) 2004-12-16 2004-12-16 Organic compounds

Publications (1)

Publication Number Publication Date
PE20060740A1 true PE20060740A1 (es) 2006-09-04

Family

ID=34090175

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005001448A PE20060740A1 (es) 2004-12-16 2005-12-14 Proceso de fabricacion de derivados de salicilamidas n-sustituidas

Country Status (24)

Country Link
US (1) US8461385B2 (https=)
EP (2) EP2955171A1 (https=)
JP (1) JP5224816B2 (https=)
KR (1) KR101287233B1 (https=)
CN (1) CN101080384B (https=)
AR (1) AR055007A1 (https=)
AU (1) AU2005315850B2 (https=)
BR (1) BRPI0519327A2 (https=)
CA (1) CA2587213C (https=)
ES (1) ES2547349T3 (https=)
GB (1) GB0427603D0 (https=)
GT (1) GT200500353A (https=)
IL (1) IL183366A0 (https=)
MA (1) MA29092B1 (https=)
MX (1) MX2007007211A (https=)
NO (1) NO338969B1 (https=)
PE (1) PE20060740A1 (https=)
PL (1) PL1838664T3 (https=)
PT (1) PT1838664E (https=)
RU (1) RU2404158C2 (https=)
TN (1) TNSN07229A1 (https=)
TW (1) TW200635880A (https=)
WO (1) WO2006063821A1 (https=)
ZA (1) ZA200703826B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20100241A1 (es) 2005-09-19 2010-04-16 Emisphere Tech Inc Formas cristalinas de la sal di-sodio del acido n-(5-clorosaliciloil)-8-aminocaprilico
NZ585080A (en) 2007-11-02 2012-05-25 Emisphere Tech Inc Composition comprising Vitamin B12 and N-[8-(2-hydroxybenzoyl) amino ]caprylic acid and salts thereof for treating Vitamin B12 deficiency
CN109473182B (zh) * 2018-11-12 2021-10-19 北京北排科技有限公司 一种基于深度信念网络的mbr膜透水率智能检测方法
EP3972961B1 (en) * 2019-05-20 2023-07-05 Lonza Guangzhou Pharmaceutical Ltd. Method for preparation of carsalam
CN115260116B (zh) * 2022-08-19 2024-04-12 株洲壹诺生物技术有限公司 8-(2-羟基苯甲酰胺基)辛酸钠及苯并噁嗪-2,4-二酮和8-溴辛酸乙酯的制法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU382610A1 (ru) * 1968-07-08 1973-05-25 Способ получения амидов карбоновых кислот
EP1175390B1 (en) * 1999-04-05 2005-02-02 Emisphere Technologies, Inc. Disodium salts, monohydrates, and ethanol solvates
TNSN00139A1 (fr) * 1999-06-25 2005-11-10 Inst For Pharm Discovery Inc Acides phenoxyacetiques substitues
ES2386263T3 (es) 2000-03-21 2012-08-14 Emisphere Technologies, Inc. Método de preparación de salicilamidas alquiladas mediante un producto intermedio de dicarboxilato
WO2001092206A1 (en) 2000-06-02 2001-12-06 Emisphere Technologies, Inc. Method of preparing salicylamides
US7227033B2 (en) * 2002-01-09 2007-06-05 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate
JP2004521857A (ja) * 2000-06-29 2004-07-22 エミスフェアー・テクノロジーズ・インク 活性剤の送達のための化合物及び組成物
WO2002019969A2 (en) * 2000-09-06 2002-03-14 Emisphere Technologies Inc. (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
CN1332711C (zh) 2002-02-20 2007-08-22 埃米球科技有限公司 施用glp－1分子的方法
US20050054557A1 (en) * 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin

Also Published As

Publication number Publication date
IL183366A0 (en) 2007-09-20
EP2955171A1 (en) 2015-12-16
JP5224816B2 (ja) 2013-07-03
BRPI0519327A2 (pt) 2009-01-13
CN101080384B (zh) 2011-06-15
AR055007A1 (es) 2007-08-01
MX2007007211A (es) 2007-08-15
KR20070086276A (ko) 2007-08-27
RU2007126972A (ru) 2009-01-27
AU2005315850A1 (en) 2006-06-22
CA2587213A1 (en) 2006-06-22
JP2008524142A (ja) 2008-07-10
CN101080384A (zh) 2007-11-28
TW200635880A (en) 2006-10-16
PL1838664T3 (pl) 2016-04-29
ES2547349T3 (es) 2015-10-05
TNSN07229A1 (en) 2008-11-21
NO20073548L (no) 2007-09-17
AU2005315850B2 (en) 2009-11-05
GT200500353A (es) 2006-07-17
KR101287233B1 (ko) 2013-07-17
GB0427603D0 (en) 2005-01-19
CA2587213C (en) 2015-05-19
MA29092B1 (fr) 2007-12-03
US8461385B2 (en) 2013-06-11
PT1838664E (pt) 2015-10-16
US20090253811A1 (en) 2009-10-08
WO2006063821A1 (en) 2006-06-22
EP1838664B1 (en) 2015-07-15
ZA200703826B (en) 2008-08-27
RU2404158C2 (ru) 2010-11-20
NO338969B1 (no) 2016-11-07
EP1838664A1 (en) 2007-10-03

Similar Documents

Publication Publication Date Title
TW200739893A (en) Manufacturing method of solid-state image sensor module
CO5271720A1 (es) Proceso para fabricar selectivamente hemipentahidrato y monopentahidrato de acido 3-piridil-12hidroxi-etiliden-1, 1-bisfofosnico sodio y composicion farmacetica que las contiene
PE20060298A1 (es) Derivados de acido carboxilico de bencimidazolona
NZ593214A (en) Compounds and Processes for preparing serine protease inhibitors
ES2191977T3 (es) Soluciones y dispersiones en estado solido de farmacos poco solubles en agua.
CL2009002097A1 (es) Mezcla herbicida que contiene picolinafeno y por lo menos un compuesto herbicida seleccionado entre acidos quinolincarboxilicos, quinclorac o el quinmerac; agente herbicida que contiene la mezcla; procedimiento para preparar dicho agente herbicida. (divisional 523-04)
TR200103095T2 (tr) Renin engelleyiciler.
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
GB0229695D0 (en) Solid-phase preparation of 18F-labelled amino acids
YU37904A (sh) Benzimidazoli kao korisni inhibitori proteinske kinaze
PE20060740A1 (es) Proceso de fabricacion de derivados de salicilamidas n-sustituidas
NO20034667D0 (no) Arylsulfonamider som antivirale midler
DE60320575D1 (de) Brausezusammensetzungen
GT200100251A (es) Procedimiento para la preparacion de imidazotriazinonas substituidas con sulfonamida
EA200400782A1 (ru) Композиция изотретиноина с измельчением компонентов до степени наночастиц
GEP20094786B (en) 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
EA200601589A1 (ru) Производные 7h-8,9-дигидропирано-(2,3-c)имидазо(1,2a)пиридина и их применение в качестве ингибиторов секреции кислоты желудочного сока
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
ATE315932T1 (de) Hemmer für das 20-hete-produzierende enzym
EA200400417A1 (ru) Новые безводные кристаллические формы габапентина
MX2007007273A (es) Procedimiento de fabricacion de salicilamidas n-sustituidas.
AR022647A1 (es) Proceso para preparar una formulacion de liberacion sostenida
EA200101113A1 (ru) Способ получения 2-(n-фениламино) бензойных кислот
ATE275577T1 (de) Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung
PE20091776A1 (es) 4-butiratos de trimetilamonio como inhibidores de la cpt2

Legal Events

Date Code Title Description
FD Application declared void or lapsed